Story · United States Senate
Senate Panel Advances Bipartisan Bill Capping Private Insurance Insulin at $35
A bipartisan bill to cap the cost of insulin at $35 for people with private health insurance advanced through the Senate Health, Education, Labor and Pensions Committee on Wednesday. The measure passed by a 17-5 vote, with six Republicans joining all Democrats on the panel in support. Despite this committee approval, the legislation's future remains uncertain as it faces potential hurdles in the full Senate. The bill aims to lower out-of-pocket costs for insulin, a critical medication for diabetes patients, and represents a rare area of bipartisan cooperation on healthcare policy.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection